Endothelin Receptor Antagonist Ambrisentan, SGLT2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy

DOI: 10.1681/asn.0000001097Author: Qinlan Chen et al.Published: 2026-4-8

Title: Endothelin Receptor Antagonist Ambrisentan, SGLT2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy
Journal: Journal of the American Society of Nephrology
Authors: Qinlan Chen, Pei Chen, Lijun Liu, Sufang Shi, Xujie Zhou, Hongyu Yang, Yang Li, Ling Guo, Sainan Zhu, Jinwei Wang, Yunfei Bao, Qiong Zhang, Muqing Liu, Xiaoyuan Ning, Yuting Cai, Rong He, Yanjie Liu, Qian Wang, Jicheng Lv, Hong Zhang
Date: 2026-4-8
DOI: 10.1681/asn.0000001097
Source: Ovid Technologies (Wolters Kluwer Health)
Source URL: https://doi.org/10.1681/asn.0000001097